Jiangsu Science Biotechnology Co., Ltd. was founded on June 9, 2020, focusing on the research, development, production and sales of medical polymer materials, and is committed to becoming the world's leader in medical sponge materials. The company's standardized production base is located at the 5th floor of G128 Building, Phase 5, Taizhou China Pharmaceutical City. The project investment is more than 40 million yuan, and nearly 3000 square meters of 100000/10000 grade clean workshop and its supporting production and office facilities have been built.
The company is mainly engaged in the development and application of medical polyvinyl alcohol (PVA) polymer porous materials, and its products cover the second class of medical products, such as ear, nose and throat rapid expansion hemostatic sponge, brain surgery PVA sponge, oral expansion hemostatic sponge, new polymer cervical expansion rod for gynecological examination, closed negative pressure drainage wound dressing for open wound treatment and disposable micro-negative pressure wound care materials.
The company pays attention to R&D investment and product innovation, and takes returned students as the main core technical team. There are 4 people with master's degree or above and 15 people with bachelor's degree. Since its establishment, the company has applied for 4 invention patents and 5 utility model patents. At the beginning of 2022, it has obtained the registration batch number of the nasal cavity swelling hemostatic sponge, the disposable wound protection sponge set for sealing negative pressure drainage, and will soon obtain the registration batch number of the disposable PVA wound care material, the PVA sponge new type cervical dilator and other Class II medical device products.
" Focusing on the research, development, production and sales of medical polymer materials, and is committed to becoming the world's leader in medical sponge materials "